Annual CAPEX
$803.00 K
-$121.00 K-13.10%
December 31, 2023
Summary
- As of February 8, 2025, VVOS annual capital expenditures is $803.00 thousand, with the most recent change of -$121.00 thousand (-13.10%) on December 31, 2023.
- During the last 3 years, VVOS annual CAPEX has risen by +$683.00 thousand (+569.17%).
- VVOS annual CAPEX is now -66.49% below its all-time high of $2.40 million, reached on December 31, 2021.
Performance
VVOS CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CAPEX
$192.00 K
+$132.00 K+220.00%
September 30, 2024
Summary
- As of February 8, 2025, VVOS quarterly capital expenditures is $192.00 thousand, with the most recent change of +$132.00 thousand (+220.00%) on September 30, 2024.
- Over the past year, VVOS quarterly CAPEX has stayed the same.
- VVOS quarterly CAPEX is now -85.35% below its all-time high of $1.31 million, reached on June 30, 2021.
Performance
VVOS Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CAPEX
$568.00 K
+$38.00 K+7.17%
September 30, 2024
Summary
- As of February 8, 2025, VVOS TTM capital expenditures is $568.00 thousand, with the most recent change of +$38.00 thousand (+7.17%) on September 30, 2024.
- Over the past year, VVOS TTM CAPEX has stayed the same.
- VVOS TTM CAPEX is now -76.29% below its all-time high of $2.40 million, reached on December 31, 2021.
Performance
VVOS TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
VVOS CAPEX Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -13.1% | 0.0% | 0.0% |
| 3 y3 years | +569.2% | -56.5% | -73.1% |
| 5 y5 years | -35.8% | -26.7% | +50.7% |
VVOS CAPEX Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -66.5% | at low | -61.9% | +220.0% | -76.3% | +7.2% |
| 5 y | 5-year | -66.5% | +569.2% | -85.3% | +3592.3% | -76.3% | >+9999.0% |
| alltime | all time | -66.5% | +569.2% | -85.3% | +3592.3% | -76.3% | >+9999.0% |
Vivos Therapeutics CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $192.00 K(+220.0%) | $568.00 K(+7.2%) |
| Jun 2024 | - | $60.00 K(-60.3%) | $530.00 K(-25.9%) |
| Mar 2024 | - | $151.00 K(-8.5%) | $715.00 K(-11.0%) |
| Dec 2023 | $803.00 K(-13.1%) | $165.00 K(+7.1%) | $803.00 K(-4.2%) |
| Sep 2023 | - | $154.00 K(-37.1%) | $838.00 K(+6.9%) |
| Jun 2023 | - | $245.00 K(+2.5%) | $784.00 K(-24.8%) |
| Mar 2023 | - | $239.00 K(+19.5%) | $1.04 M(+12.9%) |
| Dec 2022 | $924.00 K | $200.00 K(+100.0%) | $924.00 K(-16.5%) |
| Sep 2022 | - | $100.00 K(-80.2%) | $1.11 M(-23.6%) |
| Jun 2022 | - | $504.00 K(+320.0%) | $1.45 M(-35.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | $120.00 K(-68.6%) | $2.25 M(-5.9%) |
| Dec 2021 | $2.40 M(+1896.7%) | $382.00 K(-13.4%) | $2.40 M(+13.6%) |
| Sep 2021 | - | $441.00 K(-66.4%) | $2.11 M(+25.5%) |
| Jun 2021 | - | $1.31 M(+400.4%) | $1.68 M(+345.9%) |
| Mar 2021 | - | $262.00 K(+175.8%) | $376.80 K(+214.0%) |
| Dec 2020 | $120.00 K(-31.7%) | $95.00 K(+691.7%) | $120.00 K(+380.0%) |
| Sep 2020 | - | $12.00 K(+53.8%) | $25.00 K(+92.3%) |
| Jun 2020 | - | $7800.00(+50.0%) | $13.00 K(+150.0%) |
| Mar 2020 | - | $5200.00 | $5200.00 |
| Dec 2019 | $175.60 K(-86.0%) | - | - |
| Dec 2018 | $1.25 M | - | - |
FAQ
- What is Vivos Therapeutics annual capital expenditures?
- What is the all time high annual CAPEX for Vivos Therapeutics?
- What is Vivos Therapeutics annual CAPEX year-on-year change?
- What is Vivos Therapeutics quarterly capital expenditures?
- What is the all time high quarterly CAPEX for Vivos Therapeutics?
- What is Vivos Therapeutics quarterly CAPEX year-on-year change?
- What is Vivos Therapeutics TTM capital expenditures?
- What is the all time high TTM CAPEX for Vivos Therapeutics?
- What is Vivos Therapeutics TTM CAPEX year-on-year change?
What is Vivos Therapeutics annual capital expenditures?
The current annual CAPEX of VVOS is $803.00 K
What is the all time high annual CAPEX for Vivos Therapeutics?
Vivos Therapeutics all-time high annual capital expenditures is $2.40 M
What is Vivos Therapeutics annual CAPEX year-on-year change?
Over the past year, VVOS annual capital expenditures has changed by -$121.00 K (-13.10%)
What is Vivos Therapeutics quarterly capital expenditures?
The current quarterly CAPEX of VVOS is $192.00 K
What is the all time high quarterly CAPEX for Vivos Therapeutics?
Vivos Therapeutics all-time high quarterly capital expenditures is $1.31 M
What is Vivos Therapeutics quarterly CAPEX year-on-year change?
Over the past year, VVOS quarterly capital expenditures has changed by $0.00 (0.00%)
What is Vivos Therapeutics TTM capital expenditures?
The current TTM CAPEX of VVOS is $568.00 K
What is the all time high TTM CAPEX for Vivos Therapeutics?
Vivos Therapeutics all-time high TTM capital expenditures is $2.40 M
What is Vivos Therapeutics TTM CAPEX year-on-year change?
Over the past year, VVOS TTM capital expenditures has changed by $0.00 (0.00%)